Buehlmann


/

A commitment to diagnostics

Success StorySuccess StorySuccess StorySuccess Story

Quantum Blue Routine

Easy and rapid quantification of calprotectin by Quantum Blue
Successful Introduction of Quantum Blue Routine Application in the UK at the Royal Berkshire Hospital, Reading

Evaluation of the most important Pharmacogenetics tests

Read the impressions of the University Hospital in Geneva
Dr. Michela Rebsamen from the labaratory medicine department at the University Hospital in Geneva (HUG) did an evaluation study of the most important tests in pharmacogenetics (CYP2D6, CYP2C19, CYP2C9-VKORC1 and MDR1) on the INFINITI® Analyser.

Melatonin-Check

A tool to assess your circadian rhythm
The sleep clinic in Zurzach/Luzern, Switzerland started with the Sleep Check Concept under the name of Melatonin-Check for the assessment of DLMO to diagnose circadian rhythm disorders.

GHB Screening

Fast and easy examination of samples for Gamma-Hydroxy-Butyric Acid
Lars Abrahamsson, manager responsible for the drug of abuse laboratory, Trollhättan, Sweden, has successfully evaluated and introduced into routine work the new BÜHLMANN enzymatic GHB assay.


Dossier

KRAS and Personalized Medicine

The KRAS status of a tumor helps the treating physician to choose the most effective more

Dossier

GHB - Cheap dope or bummer?

GHB well known as Liquid Ecstasy und Liquid X is voluntarily consumed not only by partygoers. more


Contact

BÜHLMANN Laboratories AG
Baselstr. 55
CH-4124 Schönenbuch
Switzerland
Fon: +41 61 487 12 12
Fax: +41 61 487 12 34
info@buhlmannlabs.ch

Your local distributor
Order
About us
Job opportunities

News

NEW OWN CALPROTECTIN REIMBURSEMENT POSITION IN SWITZERLAND

BÜHLMANN is very proud to announce that the calprotectin determination in stool starting from January 1st 2012, has an official new position in the reimb  more

New Seegene DPO Movie showing how this unique and proprietary technology is working to allow innovative multiplexing.

The unique and proprietary DPO™(Dual-Priming-Oligonucleotide) technology is the corner stone for all of the Seegene products, and it is the key to achieve  more

New EntroGen BRAF test (V600E/K/D) for the detection of important mutations found in melanoma on your real-time PCR instrument.

EntroGen has a new BRAF test that detects, beside the V600E mutation, also the V600K and the V600D, which are important mutations found in melanoma.   more

BÜHLMANN innovations and news at the JIB

At the JIB Congress in Paris, 8th – 10th November 2011, BÜHLMANN presents the MDx products of EntroGen and AutoGenomics as well as new developments of its  more

Get our RSS - Feed